Literature DB >> 20229255

Long-term prognosis in ethnic Chinese patients with unprotected left main coronary artery disease.

Hui-Chun Huang1, Hsien-Li Kao, Xue-Ming Wu, Sheoi-Shen Wang, Ron-Bin Hsu, Yi-Lwun Ho, Ming-Fong Chen.   

Abstract

OBJECTIVE: The aim of this study was to investigate the long-term outcome of unprotected left main coronary artery disease (LMCA) with different therapeutic modalities in Chinese patients.
BACKGROUND: Coronary artery bypass graft (CABG) has been considered standard therapy for patients with LMCA disease. Percutaneous coronary intervention (PCI) has recently been alternative choice for unprotected LMCA. Nevertheless, the effects on the long-term outcome of unprotected LMCA by the above-mentioned management in Chinese remains unknown.
METHODS: Patients with unprotected LMCA were enrolled at National Taiwan University Hospital from January 1996 to June 2006. Survival outcomes were obtained by the Bureau of National Health Insurance and clinical results were obtained by chart record review and telephone interview.
RESULTS: A total of 620 patients with a mean age of 67 +/- 10 years were enrolled and followed up for 1,587 +/- 1,136 days. Of these, 136 were treated with medical therapy, 336 with CABG and 148 with PCI. Clinical outcome of patients receiving medical therapy was the worst. There was no significant difference between the PCI and CABG group in the risk of cardiovascular death. Cox regression analysis showed that cardiovascular mortality was significantly associated with age (P < 0.001), diabetes mellitus (P = 0.004), LVEF (P = 0.001). In high-risk left ventricular dysfunction, the elderly and renal insufficiency patients, the long-term survival was statistically significantly better in the CABG group.
CONCLUSION: For Chinese patients with unprotected left main coronary artery disease, a significant higher risk of cardiovascular death was noted in the medical therapy group. Overall the long-term cardiovascular survival was similar in LMCA patients treated with either PCI or CABG, but CABG provided better survival outcome in high-risk subgroup patients.

Entities:  

Mesh:

Year:  2010        PMID: 20229255     DOI: 10.1007/s00392-010-0139-5

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  26 in total

1.  CABG vs. stenting--clinical implications of the SYNTAX trial.

Authors:  Thomas H Lee; L David Hillis; Elizabeth G Nabel
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245

2.  Long-term outcome of percutaneous coronary intervention for unprotected left main coronary artery disease.

Authors:  Xue-Ming Wu; Chung-Pin Liu; Wei-Cheng Lin; Hsien-Li Kao
Journal:  Int J Cardiol       Date:  2008-09-19       Impact factor: 4.164

3.  Results of stenting of unprotected left main coronary artery stenosis in patients at high surgical risk.

Authors:  C Karam; J Fajadet; B Cassagneau; J P Laurent; C Jordan; J C Laborde; J Marco
Journal:  Am J Cardiol       Date:  1998-10-15       Impact factor: 2.778

4.  Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina.

Authors: 
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

5.  Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection.

Authors:  A Black; R Cortina; I Bossi; R Choussat; J Fajadet; J Marco
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

6.  Left main coronary arterial obstruction: Long-term follow-up of 141 nonsurgical cases.

Authors:  J S Lim; W L Proudfit; F M Sones
Journal:  Am J Cardiol       Date:  1975-08       Impact factor: 2.778

7.  Atherosclerosis of the left main coronary artery: 5 years results of surgical treatment.

Authors:  F D Loop; B W Lytle; D M Cosgrove; W C Sheldon; M Irarrazaval; P C Taylor; L K Groves; A D Pichard
Journal:  Am J Cardiol       Date:  1979-08       Impact factor: 2.778

8.  Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation.

Authors:  Run-lin Gao; Bo Xu; Ji-lin Chen; Yue-jin Yang; Shu-bin Qiao; Jian-jun Li; Xue-wen Qin; Min Yao; Hai-bo Liu; Yong-jian Wu; Jin-qing Yuan; Jue Chen
Journal:  Am Heart J       Date:  2008-03       Impact factor: 4.749

Review 9.  A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis.

Authors:  Hursh Naik; Anthony J White; Tarun Chakravarty; James Forrester; Gregory Fontana; Saibal Kar; Prediman K Shah; Robert E Weiss; Raj Makkar
Journal:  JACC Cardiovasc Interv       Date:  2009-08       Impact factor: 11.195

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983

View more
  2 in total

1.  Percutaneous Coronary Intervention for Left Main Coronary Artery Disease - A Single Hospital Experience without On-Site Cardiac Surgery.

Authors:  Hsiao-Yang Cheng; Kuang-Te Wang; Wen-Hsiung Lin; Jui-Peng Tsai; Yung-Tzi Chen
Journal:  Acta Cardiol Sin       Date:  2015-07       Impact factor: 2.672

2.  TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.

Authors:  Eva S Kehmeier; Wolfgang Lepper; Martina Kropp; Christian Heiss; Ulrike Hendgen-Cotta; Jan Balzer; Mirja Neizel; Christian Meyer; Marc W Merx; Pablo E Verde; Christian Ohmann; Gerd Heusch; Malte Kelm; Tienush Rassaf
Journal:  Clin Res Cardiol       Date:  2012-05-06       Impact factor: 5.460

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.